Resiliency in Green Supply Chains of Pharmaceuticals
Küçük Resim Yok
Tarih
2024
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Springer Science and Business Media Deutschland GmbH
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
The pharmaceutical industry, a vital stakeholder in the global market, places a high priority on research and development, and the COVID-19 pandemic led to concerns in April 2020 about possible disruptions in the supply chain of medicines. The pharmaceutical industry must prioritize resilient green supply chain operations in order to mitigate potential disruptions, as indicated in industrial reports. As per the literature, green supply chain management involves the incorporation of the reduce, reuse, recycle, reclaim, and degradable principle into green supply chains, beginning from manufacturing to operations and culminating with end-of-life management. Thus, the purpose of this study is to extract the concepts to achieve the green supply chain for pharmaceutical industry, and to obtain a conceptual framework via cognitive mapping process. The findings of the analysis reveal that biodiversity and corporate social responsibility together provide a basis for the green chemistry and green pharmaceutical production. In case the medical institutions adopt recycling, reverse logistics and waste management operations, a green supply chain can be achieved. Moreover, by adding the digitalization and risk management practices, finally the resiliency in green supply chain of medicine can be attained. As a result, this paper contributes to the literature by extracting the concepts to be green in pharmaceutical supply chain and by analyzing these cognitive maps for these defined concepts. As of the knowledge of the author, this is the first paper conducting a cognitive map for green pharmaceutical supply chains. In addition, practitioner can benefit from this research findings to determine the tactical and strategical plans for their institutions. Accordingly, risk management and digitalization applications plus the green pharmaceutical supply chain brings resiliency. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2024.
Açıklama
Anahtar Kelimeler
Drug, Green Supply Chain, Healthcare, Medication, Medicine, Pharmaceutical, Supply Chain, Sustainability
Kaynak
Studies in Systems, Decision and Control
WoS Q Değeri
Scopus Q Değeri
Q4
Cilt
513
